| C6S | Chondroitin 6 sulphate |
| ERT | Enzyme replacement therapy |
| FC | Fold change |
| GAG | Glycosaminoglycan |
| GALNS | N-acetylgalactosamine-6-sulfatase |
| KS | Keratan sulphateJ |
| LC | Liquid chromatography |
| MPS IVA | Mucopolysaccharidosis type IVA |
| MRM | Multiple reaction monitoring |
| MS | Mass spectrometry |
| NLC | Nanostructure lipid carrier |
| S | Sample |
| SDC | Sodium dodecyl sulfate |
| SRM | Selected reaction monitoring |
| SNARE | soluble N-ethylmaleimide-sensitive factor attachment protein receptor |
| SWATH-MS | Sequential window acquisition of all theoretical mass spectra |
| UMoC | Untreated Morquio A cells |